Life Technologies Corp. (LIFE) Maintains Outperform Rating

Analysts Isaac Ro and Jeff Ares at Leerink Swann have released an update on Life Technologies Corp. (NASDAQ: LIFE). The company will soon launch new Attune platform for flow cytometry.

Analysts believe that the launch highlights the company’s underappreciated pipeline of new products. Management at Life Technologies is targeting a $100 million revenue contribution from current and future versions of Attune by FY15 and notes that initial customer interest has been strong with positive feedback from beta users.

According to analysts, Attune is one example of the company’s commitment to sustainable growth of 100-200 basis points above its broader end markets.

Analysts at Leerink Swann continue to rate Life Technologies Corp. as Outperform and maintain their $58-$62 valuation range for the company.